Eastwood Ev To Sales vs Days Sales Outstanding Analysis

EBM Stock

CAD 0.75 0.05 6.25%

Eastwood Bio-Medical financial indicator trend analysis is much more than just examining Eastwood Bio Medical latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Eastwood Bio Medical is a good investment. Please check the relationship between Eastwood Bio-Medical Ev To Sales and its Days Sales Outstanding accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eastwood Bio Medical Canada. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Ev To Sales vs Days Sales Outstanding

Ev To Sales vs Days Sales Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Eastwood Bio Medical Ev To Sales account and Days Sales Outstanding. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Eastwood Bio-Medical's Ev To Sales and Days Sales Outstanding is 0.96. Overlapping area represents the amount of variation of Ev To Sales that can explain the historical movement of Days Sales Outstanding in the same time period over historical financial statements of Eastwood Bio Medical Canada, assuming nothing else is changed. The correlation between historical values of Eastwood Bio-Medical's Ev To Sales and Days Sales Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Sales of Eastwood Bio Medical Canada are associated (or correlated) with its Days Sales Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Days Sales Outstanding has no effect on the direction of Ev To Sales i.e., Eastwood Bio-Medical's Ev To Sales and Days Sales Outstanding go up and down completely randomly.

Correlation Coefficient

0.96

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Days Sales Outstanding

Most indicators from Eastwood Bio-Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Eastwood Bio Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eastwood Bio Medical Canada. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to climb to about 858.4 K in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.62 in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	902.7K	440.5K	506.6K	439.0K
Total Revenue	1.3M	867.9K	998.1K	907.6K

Gross Profit Total Revenue

Eastwood Bio-Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Other Current Assets	Total Liab	Total Current Assets	Common Stock	Other Stockholder Equity	Inventory	Net Invested Capital	Net Working Capital	Property Plant And Equipment Net	Capital Stock	Short Term Debt	Property Plant Equipment	Other Assets
Total Assets		0.35	0.33	0.6	0.56	-0.41	-0.58	0.98	-0.69	0.58	0.57	0.65	-0.76	0.79	0.32	0.99	-0.56	0.45	-0.84	0.97	0.98	-0.77	0.45	-0.91	-0.88	0.91
Other Current Liab	0.35		1.0	-0.54	-0.58	-0.28	0.52	0.46	-0.11	-0.52	-0.5	0.78	-0.73	0.75	1.0	0.36	-0.96	0.11	-0.45	0.26	0.29	-0.29	0.11	-0.28	-0.28	0.2
Total Current Liabilities	0.33	1.0		-0.55	-0.59	-0.26	0.52	0.44	-0.08	-0.53	-0.51	0.76	-0.72	0.75	1.0	0.34	-0.95	0.1	-0.44	0.24	0.27	-0.29	0.1	-0.27	-0.27	0.18
Total Stockholder Equity	0.6	-0.54	-0.55		0.99	-0.17	-0.95	0.49	-0.56	0.95	0.93	-0.07	-0.06	0.06	-0.56	0.58	0.31	0.37	-0.35	0.65	0.64	-0.44	0.37	-0.56	-0.54	0.65
Net Tangible Assets	0.56	-0.58	-0.59	0.99		-0.08	-0.97	0.44	-0.48	0.96	0.94	-0.12	-0.01	0.02	-0.6	0.55	0.37	0.3	-0.33	0.6	0.59	-0.44	0.3	-0.54	-0.52	0.61
Current Deferred Revenue	-0.41	-0.28	-0.26	-0.17	-0.08		-0.07	-0.45	0.55	0.07	0.1	-0.52	0.55	-0.34	-0.26	-0.35	0.42	-0.63	0.18	-0.53	-0.46	0.1	-0.63	0.27	0.28	-0.53
Net Debt	-0.58	0.52	0.52	-0.95	-0.97	-0.07		-0.46	0.41	-1.0	-1.0	0.18	0.06	-0.12	0.53	-0.58	-0.32	-0.26	0.42	-0.57	-0.57	0.46	-0.26	0.53	0.52	-0.55
Retained Earnings	0.98	0.46	0.44	0.49	0.44	-0.45	-0.46		-0.68	0.45	0.45	0.74	-0.81	0.84	0.44	0.98	-0.67	0.39	-0.85	0.96	0.97	-0.73	0.39	-0.89	-0.84	0.89
Accounts Payable	-0.69	-0.11	-0.08	-0.56	-0.48	0.55	0.41	-0.68		-0.41	-0.37	-0.52	0.36	-0.31	-0.08	-0.65	0.32	-0.7	0.44	-0.8	-0.76	0.44	-0.7	0.6	0.62	-0.78
Cash	0.58	-0.52	-0.53	0.95	0.96	0.07	-1.0	0.45	-0.41		1.0	-0.19	-0.05	0.11	-0.54	0.57	0.33	0.26	-0.41	0.56	0.56	-0.46	0.26	-0.52	-0.52	0.54
Cash And Short Term Investments	0.57	-0.5	-0.51	0.93	0.94	0.1	-1.0	0.45	-0.37	1.0		-0.21	-0.08	0.15	-0.51	0.57	0.31	0.24	-0.43	0.54	0.55	-0.44	0.24	-0.51	-0.5	0.52
Net Receivables	0.65	0.78	0.76	-0.07	-0.12	-0.52	0.18	0.74	-0.52	-0.19	-0.21		-0.72	0.69	0.76	0.67	-0.87	0.27	-0.56	0.67	0.69	-0.61	0.27	-0.7	-0.66	0.61
Common Stock Shares Outstanding	-0.76	-0.73	-0.72	-0.06	-0.01	0.55	0.06	-0.81	0.36	-0.05	-0.08	-0.72		-0.94	-0.72	-0.75	0.86	-0.38	0.77	-0.68	-0.69	0.5	-0.38	0.63	0.6	-0.6
Other Current Assets	0.79	0.75	0.75	0.06	0.02	-0.34	-0.12	0.84	-0.31	0.11	0.15	0.69	-0.94		0.75	0.79	-0.85	0.26	-0.85	0.67	0.69	-0.56	0.26	-0.64	-0.61	0.57
Total Liab	0.32	1.0	1.0	-0.56	-0.6	-0.26	0.53	0.44	-0.08	-0.54	-0.51	0.76	-0.72	0.75		0.34	-0.95	0.1	-0.43	0.23	0.26	-0.28	0.1	-0.26	-0.27	0.17
Total Current Assets	0.99	0.36	0.34	0.58	0.55	-0.35	-0.58	0.98	-0.65	0.57	0.57	0.67	-0.75	0.79	0.34		-0.56	0.4	-0.85	0.95	0.97	-0.82	0.4	-0.94	-0.9	0.87
Common Stock	-0.56	-0.96	-0.95	0.31	0.37	0.42	-0.32	-0.67	0.32	0.33	0.31	-0.87	0.86	-0.85	-0.95	-0.56		-0.22	0.62	-0.5	-0.52	0.4	-0.22	0.48	0.46	-0.43
Other Stockholder Equity	0.45	0.11	0.1	0.37	0.3	-0.63	-0.26	0.39	-0.7	0.26	0.24	0.27	-0.38	0.26	0.1	0.4	-0.22		-0.16	0.51	0.46	-0.29	1.0	-0.27	-0.39	0.5
Inventory	-0.84	-0.45	-0.44	-0.35	-0.33	0.18	0.42	-0.85	0.44	-0.41	-0.43	-0.56	0.77	-0.85	-0.43	-0.85	0.62	-0.16		-0.73	-0.77	0.59	-0.16	0.75	0.68	-0.62
Net Invested Capital	0.97	0.26	0.24	0.65	0.6	-0.53	-0.57	0.96	-0.8	0.56	0.54	0.67	-0.68	0.67	0.23	0.95	-0.5	0.51	-0.73		0.99	-0.72	0.51	-0.89	-0.86	0.96
Net Working Capital	0.98	0.29	0.27	0.64	0.59	-0.46	-0.57	0.97	-0.76	0.56	0.55	0.69	-0.69	0.69	0.26	0.97	-0.52	0.46	-0.77	0.99		-0.78	0.46	-0.93	-0.9	0.93
Property Plant And Equipment Net	-0.77	-0.29	-0.29	-0.44	-0.44	0.1	0.46	-0.73	0.44	-0.46	-0.44	-0.61	0.5	-0.56	-0.28	-0.82	0.4	-0.29	0.59	-0.72	-0.78		-0.29	0.86	0.96	-0.71
Capital Stock	0.45	0.11	0.1	0.37	0.3	-0.63	-0.26	0.39	-0.7	0.26	0.24	0.27	-0.38	0.26	0.1	0.4	-0.22	1.0	-0.16	0.51	0.46	-0.29		-0.27	-0.39	0.5
Short Term Debt	-0.91	-0.28	-0.27	-0.56	-0.54	0.27	0.53	-0.89	0.6	-0.52	-0.51	-0.7	0.63	-0.64	-0.26	-0.94	0.48	-0.27	0.75	-0.89	-0.93	0.86	-0.27		0.93	-0.82
Property Plant Equipment	-0.88	-0.28	-0.27	-0.54	-0.52	0.28	0.52	-0.84	0.62	-0.52	-0.5	-0.66	0.6	-0.61	-0.27	-0.9	0.46	-0.39	0.68	-0.86	-0.9	0.96	-0.39	0.93		-0.84
Other Assets	0.91	0.2	0.18	0.65	0.61	-0.53	-0.55	0.89	-0.78	0.54	0.52	0.61	-0.6	0.57	0.17	0.87	-0.43	0.5	-0.62	0.96	0.93	-0.71	0.5	-0.82	-0.84

Click cells to compare fundamentals

Eastwood Bio-Medical Account Relationship Matchups

Eastwood Bio-Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	933.4K	691.1K	584.5K	489.1K	440.2K	418.2K
Other Current Liab	384.6K	727.0K	731.6K	1.1M	1.0M	545.4K
Total Current Liabilities	450.9K	804.1K	844.0K	1.3M	1.2M	605.1K
Total Stockholder Equity	459.3K	(144.3K)	(294.2K)	(840.8K)	(756.7K)	(718.9K)
Net Tangible Assets	1.3M	459.3K	(144.3K)	(294.2K)	(264.8K)	(251.5K)
Current Deferred Revenue	6.9K	24.1K	24.6K	72.3K	83.1K	87.3K
Net Debt	(99.4K)	10.5K	22.4K	4.6K	5.3K	5.6K
Retained Earnings	(4.2M)	(4.8M)	(5.0M)	(5.5M)	(5.0M)	(4.7M)
Accounts Payable	59.3K	53.0K	60.3K	101.7K	117.0K	122.8K
Cash	122.7K	20.9K	39.8K	18.4K	16.6K	15.8K
Cash And Short Term Investments	122.7K	20.9K	39.8K	18.4K	16.6K	15.8K
Net Receivables	9.7K	6.0K	14.6K	82.8K	74.5K	70.8K
Liabilities And Stockholders Equity	933.4K	691.1K	584.5K	489.1K	440.2K	418.2K
Other Current Assets	40.2K	31.0K	47.0K	49.7K	44.8K	42.5K
Total Liab	474.1K	835.4K	878.7K	1.3M	1.2M	611.6K
Total Current Assets	172.6K	57.9K	101.5K	151.0K	135.9K	129.1K
Non Current Assets Total	760.8K	633.3K	483.1K	338.2K	388.9K	458.8K
Non Currrent Assets Other	402.4K	111.2K	83.4K	37.1K	42.6K	40.5K
Net Invested Capital	482.5K	(113.0K)	(231.9K)	(778.8K)	(700.9K)	(665.9K)
Net Working Capital	(278.3K)	(746.2K)	(742.5K)	(1.2M)	(1.1M)	(1.0M)
Property Plant And Equipment Net	649.6K	549.9K	446.0K	338.2K	388.9K	495.5K
Property Plant Equipment	456.6K	649.6K	549.9K	446.0K	512.9K	520.2K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Eastwood Stock Analysis

When running Eastwood Bio-Medical's price analysis, check to measure Eastwood Bio-Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio-Medical is operating at the current time. Most of Eastwood Bio-Medical's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio-Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio-Medical's price. Additionally, you may evaluate how the addition of Eastwood Bio-Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC